PROCEPT BioRobotics(PRCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PRCT PROCEPT BioRobotics

Pre-Mkt 06-24 08:39:11 EDT

20.60

-0.46

-2.18%

盘前21.32

+0.72+3.50%

08:34 EDT

High21.50	Low19.92	Vol2.03M
Open21.26	D1 Closing21.06	Amplitude7.50%
Mkt Cap1.17B	Tradable Cap1.10B	Total Shares56.91M
T/O41.21M	T/O Rate3.78%	Tradable Shares53.56M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PRCT","market":"US","secType":"STK","nameCN":"PROCEPT BioRobotics","latestPrice":20.6,"timestamp":1782244800000,"preClose":21.06,"halted":0,"volume":2026041,"hourTrading":{"tag":"盘前","latestPrice":21.32,"preClose":20.6,"latestTime":"08:34 EDT","volume":666,"amount":13951.738962000001,"timestamp":1782304478791,"change":0.72,"changeRate":0.034951,"amplitude":0.030097},"delay":0,"changeRate":-0.02184235517568838,"floatShares":53564164,"shares":56909414,"eps":-1.832336,"marketStatus":"Pre-Mkt","change":-0.46,"latestTime":"06-24 08:39:11 EDT","open":21.26,"high":21.5,"low":19.92,"amount":41209651.653549,"amplitude":0.075024,"askPrice":21.37,"askSize":201,"bidPrice":21.03,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-1.832336,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1782307800000},"marketStatusCode":1,"adr":0,"listingDate":1631678400000,"exchange":"NASDAQ","adjPreClose":20.6,"preHourTrading":{"tag":"盘前","latestPrice":21.32,"preClose":20.6,"latestTime":"08:34 EDT","volume":666,"amount":13951.738962000001,"timestamp":1782304478791,"change":0.72,"changeRate":0.034951,"amplitude":0.030097},"postHourTrading":{"tag":"盘后","latestPrice":21.01,"preClose":20.6,"latestTime":"19:58 EDT","volume":40183,"amount":827867.485,"timestamp":1782259112279,"change":0.41,"changeRate":0.019903,"amplitude":0.019903},"volumeRatio":0.8110186532236395,"impliedVol":0.7206,"impliedVolPercentile":0.644},"requestUrl":"/m/hq/s/PRCT/wiki","defaultTab":"wiki","newsList":[{"id":"2645940897","title":"Evercore ISI Initiates Coverage on PROCEPT BioRobotics With Outperform Rating, $30 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2645940897","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645940897?lang=en_us&edition=fundamental","pubTime":"2026-06-24 19:26","pubTimestamp":1782300409,"startTime":"0","endTime":"0","summary":"PROCEPT BioRobotics (PRCT) has an average rating of overweight and mean price target of $31.40, according to analysts polled by FactSet.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645894054","title":"Procept Biorobotics Initiated at Outperform by Evercore ISI Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2645894054","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645894054?lang=en_us&edition=fundamental","pubTime":"2026-06-24 18:40","pubTimestamp":1782297600,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRCT/analyst-ratings(END) Dow Jones NewswiresJune 24, 2026 06:40 ET","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRCT","LU2324357040.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645345894","title":"Procept BioRobotics initiated with an Outperform at Evercore ISI","url":"https://stock-news.laohu8.com/highlight/detail?id=2645345894","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645345894?lang=en_us&edition=fundamental","pubTime":"2026-06-24 18:10","pubTimestamp":1782295859,"startTime":"0","endTime":"0","summary":"Evercore ISI analyst Vijay Kumar initiated coverage of Procept BioRobotics (PRCT) with an Outperform rating and $30 price target Over next 12 mon, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/procept-biorobotics-initiated-with-an-outperform-at-evercore-isi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/procept-biorobotics-initiated-with-an-outperform-at-evercore-isi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","LU2324357040.USD","PRCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645919208","title":"Procept Biorobotics Corp : Evercore Isi Initiates Coverage with Outperform Rating; Price Target $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2645919208","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645919208?lang=en_us&edition=fundamental","pubTime":"2026-06-24 18:02","pubTimestamp":1782295350,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nFWN42W02D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRCT","BK4082","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645800708","title":"Analysts’ Top Healthcare Picks: PROCEPT BioRobotics (PRCT), Prime Medicine, Inc. (PRME)","url":"https://stock-news.laohu8.com/highlight/detail?id=2645800708","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645800708?lang=en_us&edition=fundamental","pubTime":"2026-06-23 18:30","pubTimestamp":1782210611,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on PROCEPT BioRobotics (PRCT), Prime Medicine, Inc. (PR...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-procept-biorobotics-prct-prime-medicine-inc-prme-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-procept-biorobotics-prct-prime-medicine-inc-prme-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","PRCT","BK4082","HCSG","BK4139","LABU","LU0128526141.USD","LU2324357040.USD","BK4585","BK4588","XBI","BK4137","LU0029874061.USD","XLV","PRME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645885042","title":"PROCEPT BioRobotics (PRCT) Is Down 6.5% After Institutional Ownership Surges Past Shares Outstanding Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2645885042","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645885042?lang=en_us&edition=fundamental","pubTime":"2026-06-23 14:32","pubTimestamp":1782196336,"startTime":"0","endTime":"0","summary":"Recent coverage shows PROCEPT BioRobotics, a surgical robotics company focused on urology, reporting strong year-over-year revenue and net profit growth alongside rising institutional ownership, even as technical indicators point to more sell than buy signals.\nAn interesting angle is that institutional shareholding has risen to more than total shares outstanding, suggesting heavy involvement from major asset managers despite the company’s still-low operating efficiency.\nWe’ll now examine how...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prct/procept-biorobotics/news/procept-biorobotics-prct-is-down-65-after-institutional-owne","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prct/procept-biorobotics/news/procept-biorobotics-prct-is-down-65-after-institutional-owne","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PRCT","LU2324357040.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644909804","title":"PROCEPT BioRobotics (PRCT) Stock Could Be 14% Undervalued After Growth Outlook Holds","url":"https://stock-news.laohu8.com/highlight/detail?id=2644909804","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644909804?lang=en_us&edition=fundamental","pubTime":"2026-06-20 22:24","pubTimestamp":1781965441,"startTime":"0","endTime":"0","summary":"A fresh batch of commentary on PROCEPT BioRobotics (PRCT) is drawing attention to the stock after a recent summary highlighted rapid revenue scaling, expanding gross margins, and slightly lower management guidance.\nSee our latest analysis for PROCEPT BioRobotics.\nDespite the fresh commentary around high revenue growth and expanding margins, PROCEPT BioRobotics’ share price return tells a different story. The stock is down 24.9% over 30 days and the 1 year total shareholder return has declined...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prct/procept-biorobotics/news/procept-biorobotics-prct-stock-could-be-14-undervalued-after","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prct/procept-biorobotics/news/procept-biorobotics-prct-stock-could-be-14-undervalued-after","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2324357040.USD","BK4082","CEO","PRCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642236708","title":"PROCEPT BioRobotics Shares Drop After Downgrade From Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2642236708","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642236708?lang=en_us&edition=fundamental","pubTime":"2026-06-12 02:19","pubTimestamp":1781201972,"startTime":"0","endTime":"0","summary":"PROCEPT BioRobotics  shares were down 5.8% in afternoon trading on Thursday after Leerink Partners downgraded the company's stock to market perform from outperform and adjusted the price target to $29 from $31.Trading volume stood at more than 1.8 million shares against a daily average of about 1.4 million.Price: 27.42, Change: -1.68, Percent Change: -5.76","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642823859","title":"PROCEPT BioRobotics Cut to Market Perform From Outperform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2642823859","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642823859?lang=en_us&edition=fundamental","pubTime":"2026-06-11 22:43","pubTimestamp":1781188980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRCT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 11, 2026 10:43 ET (14:43 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642854322","title":"Leerink Partners Downgrades PROCEPT BioRobotics to Market Perform From Outperform, Adjusts PT to $29 From $31","url":"https://stock-news.laohu8.com/highlight/detail?id=2642854322","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642854322?lang=en_us&edition=fundamental","pubTime":"2026-06-11 18:32","pubTimestamp":1781173941,"startTime":"0","endTime":"0","summary":"PROCEPT BioRobotics (PRCT) has an average rating of overweight and mean price target of $31.40, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fro","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642285675","title":"Procept Biorobotics Corp : Leerink Partners Cuts to Market Perform From Outperform; Cuts Target Price to $29 From $31","url":"https://stock-news.laohu8.com/highlight/detail?id=2642285675","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642285675?lang=en_us&edition=fundamental","pubTime":"2026-06-11 18:29","pubTimestamp":1781173780,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nFWN42J0AU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","BK4082","PRCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642285598","title":"Procept BioRobotics downgraded to Market Perform from Outperform at Leerink","url":"https://stock-news.laohu8.com/highlight/detail?id=2642285598","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642285598?lang=en_us&edition=fundamental","pubTime":"2026-06-11 18:12","pubTimestamp":1781172751,"startTime":"0","endTime":"0","summary":"Leerink downgraded Procept BioRobotics (PRCT) to Market Perform from Outperform with a $29 price target Published first on TheFly – the ultimate so...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/procept-biorobotics-downgraded-to-market-perform-from-outperform-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/procept-biorobotics-downgraded-to-market-perform-from-outperform-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRCT","BK4082","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642840867","title":"Top PROCEPT BioRobotics Executive Makes Notable Stock Move","url":"https://stock-news.laohu8.com/highlight/detail?id=2642840867","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642840867?lang=en_us&edition=fundamental","pubTime":"2026-06-11 10:06","pubTimestamp":1781143608,"startTime":"0","endTime":"0","summary":"New insider activity at PROCEPT BioRobotics ( ($PRCT) ) has taken place on June 10, 2026. PROCEPT BioRobotics’ Executive Vice President and Chief F...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-procept-biorobotics-executive-makes-notable-stock-move-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-procept-biorobotics-executive-makes-notable-stock-move-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRCT","LU2324357040.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642797254","title":"PROCEPT BioRobotics Shareholders Back Board, Pay and Auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=2642797254","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642797254?lang=en_us&edition=fundamental","pubTime":"2026-06-11 05:32","pubTimestamp":1781127165,"startTime":"0","endTime":"0","summary":"An announcement from PROCEPT BioRobotics ( ($PRCT) ) is now available. At PROCEPT BioRobotics Corporation’s annual meeting of stockholders held on ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/procept-biorobotics-shareholders-back-board-pay-and-auditor?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/procept-biorobotics-shareholders-back-board-pay-and-auditor?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRCT","LU2324357040.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642765634","title":"Procept BioRobotics shareholders elect directors at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2642765634","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642765634?lang=en_us&edition=fundamental","pubTime":"2026-06-11 04:34","pubTimestamp":1781123676,"startTime":"0","endTime":"0","summary":"Procept BioRobotics held its annual stockholder meeting on June 9, 2026.An advisory vote on executive pay passed, without implying any change to compensation practices.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Procept Biorobotics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 10, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nNDL9tVgTJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRCT","LU2324357040.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641177905","title":"PROCEPT BioRobotics (PRCT) Is Up 5.7% After New WATER IV Trials Expand Aquablation Testing Scope","url":"https://stock-news.laohu8.com/highlight/detail?id=2641177905","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641177905?lang=en_us&edition=fundamental","pubTime":"2026-06-08 08:25","pubTimestamp":1780878357,"startTime":"0","endTime":"0","summary":"In May 2026, PROCEPT BioRobotics reported two milestones in its WATER IV prostate cancer program: full enrollment of the 280‑patient randomized trial comparing Aquablation therapy with radical prostatectomy, and FDA IDE approval for a second global randomized study comparing Aquablation with active surveillance.\nBy positioning Aquablation against both the surgical standard of care and active surveillance, PROCEPT is testing whether its robotic waterjet approach can expand treatment options...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prct/procept-biorobotics/news/procept-biorobotics-prct-is-up-57-after-new-water-iv-trials","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prct/procept-biorobotics/news/procept-biorobotics-prct-is-up-57-after-new-water-iv-trials","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2324357040.USD","PRCT","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640933960","title":"PROCEPT BioRobotics (PRCT) Receives a Buy from TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2640933960","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640933960?lang=en_us&edition=fundamental","pubTime":"2026-06-01 13:35","pubTimestamp":1780292112,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Josh Jennings reiterated a Buy rating on PROCEPT BioRobotics today and set a price target of $34.00. According to TipRanks, Jennin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/procept-biorobotics-prct-receives-a-buy-from-td-cowen-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/procept-biorobotics-prct-receives-a-buy-from-td-cowen-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4207","BK4566","COWN","PRCT","LU2324357040.USD","TD","BK4082","BK4585","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638698648","title":"Procept Biorobotics® Advances Prostate Cancer Program With Water Iv Study Enrollment Completion and Expanded Ide Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2638698648","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638698648?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:00","pubTimestamp":1779969606,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nTUAC22CPM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","PRCT","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638984556","title":"PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2638984556","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638984556?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:00","pubTimestamp":1779969600,"startTime":"0","endTime":"0","summary":"SAN JOSE, Calif., May  28, 2026  (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) today announced two milestones in its WATER IV prostate cancer clinical program: completion of enrollment in the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/28/3302797/0/en/PROCEPT-BioRobotics-Advances-Prostate-Cancer-Program-with-WATER-IV-Study-Enrollment-Completion-and-Expanded-IDE-Approval.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","BK4082","PRCT","IDE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638688011","title":"A Look At PROCEPT BioRobotics (PRCT) Valuation After Its Better Than Expected Q1 Earnings And Analyst Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2638688011","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638688011?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:11","pubTimestamp":1779883883,"startTime":"0","endTime":"0","summary":"Analyst reactions and Q1 surprise\nPROCEPT BioRobotics (PRCT) drew fresh attention after reporting better than expected fiscal Q1 results, which prompted several research updates and a double digit after hours move in the stock.\nPiper Sandler highlighted strong domestic capital placements and record average selling prices as key supports for its updated view. Baird refreshed its models on the earnings surprise but kept a more cautious stance on long term adoption.\nSee our latest analysis for...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prct/procept-biorobotics/news/a-look-at-procept-biorobotics-prct-valuation-after-its-bette","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prct/procept-biorobotics/news/a-look-at-procept-biorobotics-prct-valuation-after-its-bette","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PRCT"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.procept-biorobotics.com","stockEarnings":[{"period":"1week","weight":-0.0679},{"period":"1month","weight":-0.2897},{"period":"3month","weight":-0.174},{"period":"6month","weight":-0.3735},{"period":"1year","weight":-0.6493},{"period":"ytd","weight":-0.3452}],"compareEarnings":[{"period":"1week","weight":-0.0223},{"period":"1month","weight":-0.0162},{"period":"3month","weight":0.1169},{"period":"6month","weight":0.0626},{"period":"1year","weight":0.2223},{"period":"ytd","weight":0.0758}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.079362},{"month":2,"riseRate":0.4,"avgChangeRate":0.005067},{"month":3,"riseRate":0.6,"avgChangeRate":0.037831},{"month":4,"riseRate":0.6,"avgChangeRate":0.00923},{"month":5,"riseRate":1,"avgChangeRate":0.124767},{"month":6,"riseRate":0.2,"avgChangeRate":-0.082411},{"month":7,"riseRate":0.5,"avgChangeRate":0.00614},{"month":8,"riseRate":0.5,"avgChangeRate":0.030761},{"month":9,"riseRate":0.5,"avgChangeRate":-0.027813},{"month":10,"riseRate":0.6,"avgChangeRate":0.021826},{"month":11,"riseRate":0.4,"avgChangeRate":0.016944},{"month":12,"riseRate":0.2,"avgChangeRate":-0.059852}],"exchange":"NASDAQ","name":"PROCEPT BioRobotics","nameEN":"PROCEPT BioRobotics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PROCEPT BioRobotics(PRCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest PROCEPT BioRobotics(PRCT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"PROCEPT BioRobotics,PRCT,PROCEPT BioRobotics股票,PROCEPT BioRobotics股票老虎,PROCEPT BioRobotics股票老虎国际,PROCEPT BioRobotics行情,PROCEPT BioRobotics股票行情,PROCEPT BioRobotics股价,PROCEPT BioRobotics股市,PROCEPT BioRobotics股票价格,PROCEPT BioRobotics股票交易,PROCEPT BioRobotics股票购买,PROCEPT BioRobotics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PROCEPT BioRobotics(PRCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest PROCEPT BioRobotics(PRCT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}